课题基金 / 基金详情

INTRAVENOUS AMONAFIDE FOR PATIENTS WITH SOLID TUMORS REFRACTORY TO THERAPY

INTRAVENOUS AMONAFIDE FOR PATIENTS WITH SOLID TUMORS REFRACTORY TO THERAPY
治疗难治性实体瘤患者静脉注射 Amonafide
批准号：
3863965
负责人：
RONALD BLUM
金额：
$0.0万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3863965
关键词：
antineoplastics clinical trials drug metabolism drug tolerance human subject human therapy evaluation intravenous administration neoplasm /cancer neoplasm /cancer chemotherapy

项目摘要

项目成果

RONALD BLUM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to determine the safety, tolerance, pharmacokinetic profile, biological effects, and maximally tolerated dose of amonafide administered by intravenous infusion, once weekly on a 4-weeks on/1 week off schedule to patients with histologically documented advanced malignancies resistant or nonamenable to conventional therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECOG C9344 DOXORUBICIN DOSE ESCALATION +/- TAXOL FOR NODE POSITIVE BREAST CANCER
SWOG 94-20 CORRELATION OF THYMIDYLATE SYNTHASE IN 5 FU TREATED COLORECTAL CANCER
ECOG S9313--ADJUVANT CHEMOTHERAPY IN HIGH RISK BREAST CANCER PATIENTS
ECOG 91140--CDP, DTIC, CARMUSTINE & TAMOXIFEN VS DTIC IN ADVANCED MELANOMA
海外基金